Taduran, Keisha Kate J.

HRN: 15-62-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CEFUROXIME 750MG (VIAL)
03/22/2023
03/28/2023
IVTT
250mg
Q8h
Bronchial Asthma In Acute Exacerbation; PCAP B
Waiting Final Action 
03/24/2023
CEFUROXIME 750MG (VIAL)
03/24/2023
03/30/2023
IVT
670mg
Q8
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: